Julio Ribeiro is the co-founder and CEO of Inventia Life Science, the med-tech company behind the 3D bioprinter technology that creates realistic replicas of tumours to test cancer treatments. Julio grew up in Brazil where he studied biology and genetics, and in the 90’s he migrated to Australia to do his PhD in medicine. After working for a scientific tech supply company, he saw a gap in the market and knew that the science field had the potential to make life a lot better, so he started his company, Inventia Life Science. They developed the bioprinting platform ‘Rastrum’ to print 3D cell models in high quantity with a gel that mimics human tissue, enabling medical researchers to do higher quality experiments into cancer treatment, and potentially also the coronavirus. I ask Julio how he sees biology, computer science and engineering coming together in the next few years and where the highly disruptive sector of 3D printing has the potential to go.